Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Non-Current Deferred Tax Liability: 2018-2023

Historic Non-Current Deferred Tax Liability for Ptc Therapeutics (PTCT) over the last 6 years, with Dec 2023 value amounting to $55.9 million.

  • Ptc Therapeutics' Non-Current Deferred Tax Liability rose 7.67% to $55.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $55.9 million, marking a year-over-year increase of 7.67%. This contributed to the annual value of $55.9 million for FY2023, which is 45.64% down from last year.
  • As of FY2023, Ptc Therapeutics' Non-Current Deferred Tax Liability stood at $55.9 million, which was down 45.64% from $102.8 million recorded in FY2022.
  • In the past 5 years, Ptc Therapeutics' Non-Current Deferred Tax Liability registered a high of $137.1 million during FY2021, and its lowest value of $55.9 million during FY2023.
  • For the 3-year period, Ptc Therapeutics' Non-Current Deferred Tax Liability averaged around $98.6 million, with its median value being $102.8 million (2022).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first rose by 4.49% in 2020, then crashed by 45.64% in 2023.
  • Over the past 5 years, Ptc Therapeutics' Non-Current Deferred Tax Liability (Yearly) stood at $130.9 million in 2019, then rose by 4.49% to $136.7 million in 2020, then climbed by 0.27% to $137.1 million in 2021, then decreased by 25.00% to $102.8 million in 2022, then crashed by 45.64% to $55.9 million in 2023.